CNS PENETRATION OF THE CDK4/6 INHIBITOR RIBOCICLIB (LEE011) IN NON-TUMOR BEARING MICE AND MICE BEARING ORTHOTOPIC PEDIATRIC BRAIN TUMORS

Archive ouverte

Patel, Yogesh | Davis, Abigail | Kala, Ashish | Roberts, Jessica | Jacus, Megan | Baker, Suzanne | Roussel, Martine | Stewart, Clinton

Edité par CCSD ; Oxford University Press (OUP) -

21st Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology, Scottsdale, AZ, NOV 17-20, 2016. International audience

Consulter en ligne

Suggestions

Du même auteur

MEDULLOBLASTOMA GENOTYPE DICTATES BLOOD BRAIN BARRIER PHENOTYPE

Archive ouverte | Phoenix, Timothy | CCSD

17th International Symposium on Pediatric Neuro-Oncology (ISPNO), Liverpool, ENGLAND, JUN 12-16, 2016. International audience

Evaluation of effective drug combinations of sonidegib and ribociclib for treatment of Sonic hedgehog medulloblastoma using mathematical models of the cell cycle and Hedgehog pathways

Archive ouverte | Jones, Zack | CCSD

Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, APR 01-05, 2017. International audience

CNS Penetration and Pharmacodynamics of the CHK1 Inhibitor Prexasertib in a Mouse Group 3 Medulloblastoma Model

Archive ouverte | Campagne, Olivia | CCSD

International audience. Prexasertib (LY2606368) is a potent and selective small molecule inhibitor of cell-cycle checkpoint CHK1 and CHK2 protein kinases and is currently under clinical evaluation for treatment of p...

Chargement des enrichissements...